ESMO Highlights

flipper_slider

Editor's Choice

Dr Antonio Llombart-Cussac discusses data from the CASCADE study. FILMED AT THE EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY (ESMO) ANNUAL MEETING, OCTOBER 2016.

ESMO Highlights Videos

Dr Paolo Ascierto discusses ipilimumab and other types of immunotherapy in the treatment of melanoma. Part 2 of 2. FILMED AT THE EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY (ESMO) ANNUAL MEETING, OCTOBER 2016. WHAT HAVE BEEN THE FINDINGS ON THE USE OF IPILIMUMAB IN THE ADJUVANT SETTING? This...
Dr Paolo Ascierto discusses the advantages of ipilimumab 10 mg/kg over ipilimumab 3 mg/kg for advanced melanoma. Part 1 of 2. FILMED AT EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY (ESMO) ANNUAL MEETING, OCTOBER 2016. WHAT HAVE BEEN THE FINDINGS OF THE RECENT STUDY EVALUATING IPILIMUMAB DOSES IN...
Dr Ulrich Keilholz discusses first- and second-line treatments for recurrent/metastatic squamous cell carcinoma of the head and neck. FILMED AT THE EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY (ESMO) ANNUAL MEETING, OCTOBER 2016.
Dr Christian Marth discusses neoadjuvant chemotherapy and upfront surgery in ovarian cancer. FILMED AT THE EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY (ESMO) ANNUAL MEETING, OCTOBER 2016.
Dr Antonio Llombart-Cussac discusses data from the CASCADE study. FILMED AT THE EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY (ESMO) ANNUAL MEETING, OCTOBER 2016.
Dr Lars Bastholt discusses lenvatinib for the treatment of differentiated thyroid cancer. FILMED AT THE EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY (ESMO) ANNUAL MEETING, OCTOBER 2016.
Dr Frédéric Amant discusses surgery in ovarian cancer and the indications for fertility-sparing surgery. FILMED AT THE EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY (ESMO) ANNUAL MEETING, OCTOBER 2016.
Dr Marc Peeters, from our European Editorial Board, discusses the left/right position of colon cancer and how this affects prognosis and treatment. FILMED AT THE EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY (ESMO) ANNUAL MEETING, OCTOBER 2016.